Plant-derived SVC112 hits cancer stem cells, leaves healthy cells alone by Staff January 8, 2020 January 8, 2020 88 views 88Study shows drug SVC112 stops production of proteins that cancer stem cells need to survive and grow.Source: sciencedaily.com ScienceDaily 0 FacebookTwitterPinterestEmail previous post New auto-inflammatory disease called CRIA syndrome next post Outbreak science: Infectious disease research leads to outbreak predictions Related Posts Chemists produce new-to-nature enzyme containing boron May 8, 2024 Neuropathy very common, underdiagnosed May 8, 2024 New insight into genesis of spina bifida May 8, 2024 Exercise, new drug class recommended for management of... May 8, 2024 Heavy snowfall and rain may contribute to some... May 8, 2024 ‘Wraparound’ implants represent new approach to treating spinal... May 8, 2024